Bill Sponsor
House Bill 5442
116th Congress(2019-2020)
Lowest Price for Patients Act
Introduced
Introduced
Introduced in House on Dec 16, 2019
Overview
Text
Introduced in House 
Dec 16, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Dec 16, 2019)
Dec 16, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 5442 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 5442


To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to require pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

December 16, 2019

Ms. Porter (for herself and Ms. DeLauro) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to require pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Lowest Price for Patients Act” .

SEC. 2. Requirement for pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug.

(a) Enrollees of prescription drug coverage under a group health plan or a health insurance issuer offering group or individual health insurance coverage.—Section 2729(a) of the Public Health Service Act (42 U.S.C. 300gg–29(a)) is amended—

(1) in paragraph (1)—

(A) by striking “not restrict, directly or indirectly,” and inserting “provide that”; and

(B) by striking “from informing (or penalize such pharmacy for informing)” and inserting “inform”; and

(2) in paragraph (2)—

(A) by striking “ensure” and inserting “provide”;

(B) by striking “does not, with respect to such plan or coverage, restrict, directly or indirectly,” and inserting “requires under such contract that”; and

(C) by striking “from informing (or penalize such pharmacy for informing)” and inserting “inform”.

(b) Enrollees of prescription drug coverage under a prescription drug plan or MA–PD plan.—Section 1860D–4 of the Social Security Act (42 U.S.C. 1395w–104) is amended—

(1) by redesignating the subsection (m) as inserted by section 6063(c) of the SUPPORT for Patients and Communities Act as subsection (n); and

(2) by adding at the end the following new subsection:

“(o) Pharmacy disclosure of the price of a drug for an enrollee using and not using prescription drug coverage.—For plan year 2020 and each subsequent plan year, a PDP sponsor and a Medicare Advantage organization offering a prescription drug plan or MA–PD plan under a contract with an entity that provides pharmacy benefits management services on behalf of such MA–PD plan shall provide that each pharmacy that dispenses a coverage part D drug shall inform an enrollee of any differential between—

“(1) the price of the drug for an individual that is an enrollee under such prescription drug plan or MA–PD plan (as the case may be) using such plan; and

“(2) the price of the drug for such individual described in paragraph (1) without using such plan.”.